Book Value per Share: Prothena Biosciences (PRTA)
Prothena Corporation (PRTA) leverages scientific breakthroughs in the therapy of degenerative brain pathologies, which remain independent of market cycles. The platform's high authority and alliances with industry leaders ensure capital confidence, with the current figure standing at 5.56. This chart of the market price on GURU.Markets reflects a strategy of minimizing capital expenditures by utilizing external contractors to conduct medical tests.
Prothena Biosciences - analytical breakdowns and key metrics (PRTA)
- price and consensus price forecast:
- market capitalization data:
- book capitalization data:
- debt and liquidity data:
Fundamental company valuation:Prothena, PRTA
For the biotechnology sector, where Prothena Corporation (PRTA) is competing for patent leadership in neurodegeneration therapy, the BVPS value reflects the company's actual financial foundation. This indicator is calculated as the difference between all assets and liabilities divided by the number of shares, demonstrating the amount of equity that serves as a defensive buffer during costly clinical trials.
Competitor analysis for Prothena Corporation
Accounting Value per Share Biogen Corp BIIB|NBIX - Book Price of a Share|RGC: Book Value per Share|AXSM (axsome.com) - Book Value per Share|Net Assets per Single Share ACADIA Pharmaceuticals Inc. (ACAD)|Equity per Share Xenon Pharmaceuticals Inc.|Viking Pharma - Book Value per Share|Net Asset Value per Share Supernus Corp SUPN|Accounting Value per Share CPRX (Catalyst Pharmaceuticals)|denalitherapeutics.com - Book Value per Share|Net Assets per Single Share Harmony Biosciences Holdings, Inc. (HRMY)|BHVN: Accounting Value of a Share|Net Assets per Single Share AMLX|TRVI (Trevi Corp) - Net Asset Value per Share|Net Assets per Single Share Praxis Precision Medicines PRAX|Share Book Value AVXL|CeriBell (CBLL) - Net Assets per Single Share|Accounting Value of a Share ALEC (alector.com)|ANNX: Net Assets per Single Share|OMER - Net Asset Value per Share|Accounting Value per Share Neurogene Inc. NGNE|ACIU - Book Price of a Share|Book Value per Share Voyager Therapeutics, Inc. VYGR|Neumora (NMRA) - Accounting Value of a Share|Book Value per Share SCLX (Scilex Holding Co.)|Net Asset Value per Share TVGN|Net Assets per Single Share Alpha Cognition ACOG|Equity per Share Cognition Therapeutics Inc. (CGTX)|Book Value per Share IKT (Inhibikase Therapeutics, Inc.)|SAVA - Book Value per Share|Accounting Value per Share Assertio Therapeutics (ASRT)|COYA - Accounting Value of a Share|VTGN (vistagen.com) - Book Value per Share|OVID (Ovid Therapeutics) - Accounting Value per Share|Net Assets per Single Share ABOS (Acumen Pharmaceuticals, Inc.)|Net Asset Value per Share CRVO|Alterity Therapeutics (ATHE) - Net Assets per Single Share|Accounting Value of a Share CLNN (clene.com)|PepGen (PEPG) - Net Assets per Single Share|Jupiter Neurosciences, Inc. - Share Book Value|RLMD (Relmada Therapeutics, Inc.) - Net Assets per Single Share|ANVS: Net Asset Value per Share|Net Assets per Single Share gracetx.com GRCE|Firefly Neuro (AIFF) - Accounting Value of a Share|KLTO (ANEW Medical) - Book Value per Share|Book Value per Share NeuroSense Therapeutics, Ltd. (NRSN)|Accounting Value per Share Reviva Pharmaceuticals Holdings, Inc.|Book Price of a Share metaviatx.com (MTVA)|Book Value per Share NRXS|Helius Medical Technologies, Inc. - Net Assets per Share|PASG (Passage Bio Corp) - Net Assets per Single Share|NEUP: Net Asset Value per Share|Net Assets per Single Share Minerva Neurosciences, Inc.|ATHA (Athira Pharma Inc) - Equity per Share|Net Assets per Single Share Addex Therapeutics, Ltd. ADXN|Share Book Value ALZN|Cyclerion Therapeutics (CYCN) - Net Assets per Single Share|Accounting Value of a Share protagenic.com PTIX|Accounting Value per Share Pasithea Therapeutics Corp. (KTTA)|Book Price of a Share Cortigent Inc CRGT|Avenue Therapeutics, Inc - Book Value per Share|BCLI: Book Value per Share|Net Assets per Single Share Cara Therapeutics, Inc.|chromocell.com (CHRO) - Equity per Share|Book Value per Share ELYM (Eliem Therapeutics, Inc.)|Net Asset Value per Share Intra-Cellular (ITCI)|Accounting Value per Share LBPH|Book Value per Share MRNS (Marinus Pharma)|Net Assets per Single Share NKGen Biotech, Inc.|neurobopharma.com - Accounting Value of a Share|SAGE (Sage Therapeutics) - Net Assets per Single Share|SNPX: Net Asset Value per Share|Net Assets per Single Share Trevena, Inc (TRVN)|VIGL (Vigil Neuroscience, Inc.) - Share Book Value|WENA - Net Assets per Single Share|Accounting Value of a Share CERE